Rheumatology Headlines

Rheum in Review: SCOTUS on Fosamax, FDA Drug Approval, Secukinumab Safety, and More

Rheum in Review: SCOTUS on Fosamax, FDA Drug Approval, Secukinumab Safety, and More

Here are the top stories covered by DocWire News this week in the Rheumatology section. In this edition, read about the Supreme Court’s stance on hundreds of lawsuits against pharmaceutical giant Merck, the latest Food and Drug Administration (FDA) approval for a plaque psoriasis treatment for adolescent patients, the long-term safety of secukinumab, and how opioids may affect outcomes in joint arthroplasty patients.

Latest Abstracts

This Week's Featured Journal: Rheumatology

click me